Stock RGNX REGENXBIO INC.
Add to a list
To use this feature you must be a member
Log inSign up

Comparison Chart REGENXBIO Inc.

Equities

RGNX

US75901B1070

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-07-11 pm EDT 		5-day change 1st Jan Change
12.71 USD +18.34% Intraday chart for REGENXBIO Inc. +17.47% -29.19%
Jun. 24 Regenxbio Enrolling New Group for Phase 1/2 Duchenne Muscular Dystrophy Trial MT
Jun. 24 REGENXBIO Inc. Announces Expansion of Affinity Duchenne Trial to Include a New Cohort of Younger Patients CI
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Compared values

Sector Change 5d. change 1st Jan change 1-year change 5-years change Capi. ST MT LT
REGENXBIO INC.
Bio Therapeutic Drugs
+18.34%+17.47%-29.19%-35.91%-72.35% 626M
Bearish
Bearish
Bearish

Technical Rankings Surperformance

  1. Stock Market
  2. Equities
  3. RGNX Stock
  4. Charts REGENXBIO Inc.
  5. Comparison Chart